Moloney Securities Asset Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $75K | Sell |
|
|||||
|
2024
Q3 | $114K | Sell |
|
|||||
|
2024
Q2 | $209K | Sell |
|
|||||
|
2024
Q1 | $618K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $1.59M | Sell |
|
|||||
|
2020
Q3 | $767K | Sell |
|
|||||
|
2020
Q2 | $309K | Buy |
|
|||||
|
2020
Q1 | $74K | Sell |
|
|||||
|
2019
Q4 | $157K | Sell |
|
|||||
|
2019
Q3 | $181K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $881K | Sell |
|
|||||
|
2018
Q4 | $1.38M | Sell |
|
|||||
|
2018
Q3 | $2.53M | Buy |
|
|||||
|
2018
Q2 | $1.52M | Sell |
|
|||||
|
2018
Q1 | $932K | Buy |
|
|||||
|
2017
Q4 | $154K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $128K | Buy |
|